Genetic Association Analysis of Complex Diseases Through Information Theoretic Metrics and Linear Pleiotropy

Total Page:16

File Type:pdf, Size:1020Kb

Genetic Association Analysis of Complex Diseases Through Information Theoretic Metrics and Linear Pleiotropy GENETIC ASSOCIATION ANALYSIS OF COMPLEX DISEASES THROUGH INFORMATION THEORETIC METRICS AND LINEAR PLEIOTROPY Dissertation submitted for the degree of Doctor of Philosophy in Biomedical Engineering PhD Student: Helena Brunel Montaner PhD Advisor: Dr. Alexandre Perera i Lluna Universitat Polit`ecnicade Catalunya Programa de Doctorat en Enginyeria Biom`edica Barcelona, 2013 Abstract The main goal of this thesis was to help in the identification of genetic variants that are responsible for complex traits, combining both linear and nonlinear approaches. First, two one-locus approaches were proposed. The first one defined and characterized a novel nonlinear test of genetic association, based on the mutual information measure. This test takes into account the genetic structure of the population. It was applied to the GAW17 dataset and compared to the standard linear test of association. Since the solution of the GAW17 simulation model was known, this study served to characterize the performance of the proposed nonlinear methods in comparison to the linear one. The proposed nonlinear test was able to recover the results obtained with linear methods but also detected an additional SNP in a gene related with the phenotype. In addition, the performance of both tests in terms of their accuracy in classification (AUC) was similar. In contrast, the second approach was an exploratory study on the relationship between SNP variability among species and SNP association with disease, at different genetic regions. Two sets of SNPs were compared, one containing deleterious SNPs and the other defined by neutral SNPs. Both sets were stratified depending on the region where the polymorphisms were located, a feature that may have influenced their conservation across species. It was observed that, for most functional regions, SNPs associated to diseases tend to be significantly less variable across species than neutral SNPs. Second, a novel nonlinear methodology for multiloci genetic association was proposed with the goal of detecting association between combinations of SNPs and a phenotype. The proposed method was based on the mutual information of statistical significance, called MISS. This approach was com- pared with MLR, the standard linear method used for genetic association based on multiple linear regressions. Both were applied as a relevance crite- rion of a new multi-solution floating feature selection algorithm (MSSFFS), proposed in the context of multi-loci genetic association for complex disea- ses. Both were also compared with MECPM, an algorithm for searching predictive multi-loci interactions with a criterion of maximum entropy. The three methods were tested on the SNPs of the F7 gene, and the FVII levels in blood, with the data from the GAIT project. The proposed nonlinear i ii method (MISS) improved the results of traditional genetic association me- thods, detecting new SNP-SNP interactions. Most of the obtained sets of SNPs were in concordance with the functional results found in the litera- ture where the obtained SNPs have been described as functional elements correlated with the phenotype. Third, a linear methodological framework for the simultaneous study of several phenotypes was proposed. The methodology consisted in building new phenotypic variables, named metaphenotypes, that capture the joint activity of sets of phenotypes involved in a metabolic pathway. These new variables were used in further association tests with the aim of identifying ge- netic elements related with the underlying biological process as a whole. As a practical implementation, the methodology was applied to the GAIT project dataset with the aim of identifying genetic markers that could be related to the coagulation process as a whole and thus to thrombosis. Three mathema- tical models were used for the definition of metaphenotypes, corresponding to one PCA and two ICA models. Using this novel approach, already known associations were retrieved but also new candidates were proposed as regu- latory genes with a global effect on the coagulation pathway as a whole. Acknowledgements Writing these words is one of the most emotional moments in my life, because it closes an intense and meaningful period. Such is the gratitude that I feel that I would never have enough space to express it, but I'll try to convey it as concise as possible. I hope everyone will feel appreciated as it deserves and if there are some feelings that I have not had time to organize, I hope to get them somehow. I feel extremely lucky that I enjoyed the constant support of many people during these years so that this thesis is a prize that deserves to be shared with all who have been part of it. Before expressing my gratitude to all those who have offered me help, support and assistance throughout the development of this thesis, let me skip the protocol for a more personal appreciation, without which I do not understand this section. For me, to finish this manuscript is also a proof that I am taking the second chance given to me. And I owe it to three main groups of people. First of all, I do not even know how to express my gratitude and admiration to the infinite generosity of an anonymous family which in a painful situation were able to donate the organs of a deceased relative. I also want to thank and acknowledge the work of the several medical teams that took care of me during the last ten years, In particular, thanks to the cardiologists that treated me before the surgery for keeping me able to carry a normal life for nine years, and to the Cardiac Transplant Unit of the Hospital de Sant Pau which with their excellence have made my recovery as easy and quick as possible. Finally I want to recognize the courage and bravery of my family who have been with me at all times. Their constant support and affection have been essential for me to overcome this process and without them I would never have been able to face it. Having said that, I can now proceed to thank all the people who have contributed directly or indirectly to the development of this thesis. First of all I would like to express my gratitude to my supervisor, Dr. Alexandre Perera Lluna, for his guidance and support. These last six years working under his supervision have made me grow as a researcher and as a person. It has been a privilege to enjoy his scientific contributions and advices and to translate his exceptional ideas into my work. For me, it has been a great honor but also a big responsibility to be his first PhD student and I sincerely hope not having let him down. I am aware that the circumstances iii iv have often been unexpected, unpredictable and even awkward so that I am very grateful to him for his patience and his comprehension at all times. I would also like to thank him for his conviction on the value of this work and for encouraging me and helping me to get over my existential crises and to believe in the culmination of this manuscript. I would also acknowledge him for his concern with my employment and with my future as a researcher. So, thanks to Alex for being my supervisor and, not less important, for being a friend at the same time. I want to express my gratitude to all the people in the ESAII depart- ment at UPC, from the administrative staff to the directors, for their warm welcome and support during this years. I feel proud to have become part of the SISBIO work team, composed of people who stand out for their hu- manity and kindness. A special thank to Prof. Josep Amat for introducing me to the department and to biomedical engineering with the final project of my degree in Mathematics. I also thank Dr. Montserrat Vallverd´ufor introducing me into the world of biomedical signals, and for teaching me in my first research work. It was a very instructive period for me and I have tried to retain her teachings in my work in this thesis. Finally, I would like to thank Prof. Pere Caminal for his constant support and interest in my work and in my health but above all for conferring me the opportunity of carrying out this thesis at his research group with a grant from the IBEC Institute. The financial support of the IBEC (Institut de Bioenginyeria de Catalunya) has been essential for me to be able to devote time and energy to this thesis. I would like to thank Dr. Jos´eManuel Soria and all his team at the Unitat de Gen`omica de Malalties Complexes at Hospital de Sant Pau for his warm welcome at his research group and for his priceless comprehension and pa- tience. I am very grateful to him for waiting for me during my convalescence and I hope I will have time to compensate him with a productive work at his research group. I would also like to thank him and Angel Mart´ınez-P´erez for their straight collaboration in the studies leading to chapter 7 and 8. I would also thank the remaining members of the team for their support in the last months. I specially thank Yorgos for his guidance and support and for correcting parts of this my manuscript. Thanks also to Dr. Joan-Josep Gallardo-Chac´onfor his contribution in chapter 6. I also want to thank him for his guidance in biology. I would like to thank all the remaining colleagues in the g-sisbio group. It has been a pleasure to work with all of them and to receive their valuable comments and viewpoints about my work which in many occasions have helped to my work. I specially thank Raimon and Joan for their collabo- ration in both chapters 6 and 8.
Recommended publications
  • 2021 International Conference on Intelligent Biology and Medicine (ICIBM 2021)
    2021 International Conference on Intelligent Biology and Medicine (ICIBM 2021) August 08-10, 2021 Virtual via Zoom Hosted by: The International Association for Intelligent Biology and Medicine (IAIBM), Temple University, The Perelman School of Medicine, University of Pennsylvania, and The University of Texas Health Science Center at Houston 1 TABLE OF CONTENTS Welcome .……………………………….…………………………... 4 Acknowledgments ……………………………….…………………. 5 Schedule ……………………………….………………………….... 9 Keynote speakers’ information ……………………………….….. 24 Eminent Scholar Talks ………….……………………………….. 32 Workshop and tutorial information …………………………… 40 Session information ……………………………….……………… 46 Poster session abstracts ……………………………….…………… 107 About IAIBM ……………………………………………….……. 136 Special Acknowledgements……...……………….………………… 137 2 Sponsorships……………………………………………………… 138 3 Welcome to ICIBM 2021! On behalf of all our conference committees and organizers, we welcome you to the 2021 International Conference on Intelligent Biology and Medicine (ICIBM 2021), co-hosted by The International Association for Intelligent Biology and Medicine (IAIBM), Temple University, and the Perelman School of Medicine at the University of Pennsylvania. Given the rapid innovations in the fields of bioinformatics, systems biology, and intelligent computing and their importance to scientific research and medical advancements, we are pleased to once again provide a forum that fosters interdisciplinary discussions, educational opportunities, and collaborative efforts among these ever growing and progressing fields. We are proud to have built on the successes of previous years’ conferences to take ICIBM 2021 to the next level. This year, our keynote speakers include Drs. James S. Duncan, Chunhua Weng, Ben Raphael, and Ying Xu. We also have four eminent scholar speakers from Drs. Yue Feng, Graciela Gonzalez-Hernandez, Kai Tan, and Wei Chen. These researchers are world-renowned experts in their respective fields, and we are privileged to host their talks at ICIBM 2021.
    [Show full text]
  • Genetic, Epidemiological and Biological Analysis of Interleukin-10
    Genes and Immunity (2009) 10, 174–180 & 2009 Macmillan Publishers Limited All rights reserved 1466-4879/09 $32.00 www.nature.com/gene ORIGINAL ARTICLE Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for À819C/T in leprosy susceptibility AC Pereira1,5, VN Brito-de-Souza1,5, CC Cardoso2, IMF Dias-Baptista1, FPC Parelli1,3, J Venturini1,3, FR Villani-Moreno1, AG Pacheco4 and MO Moraes2 1Instituto Lauro de Souza Lima, Bauru, Sa˜o Paulo, Brazil; 2Laborato´rio de Hansenı´ase, Departamento de Micobacterioses, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil; 3Tropical Diseases Area, Botucatu Medical School, Sao Paulo State University, UNESP, Botucatu, Sa˜o Paulo, Brazil and 4Departamento de Epidemiologia e Me´todos Quantitativos em Sau´de (DEMQS), Escola Nacional de Sau´de Pu´blica (ENSP)/PROCC, FIOCRUZ, Rio de Janeiro, Brazil Leprosy is a complex infectious disease influenced by genetic and environmental factors. The genetic contributing factors are considered heterogeneous and several genes have been consistently associated with susceptibility like PARK2, tumor necrosis factor (TNF), lymphotoxin-a (LTA) and vitamin-D receptor (VDR). Here, we combined a case–control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (IL-10) genetic markers in leprosy. We observed that the À819T allele is associated with leprosy susceptibility either in the case–control or in the meta-analysis studies. Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the À819T allele in leprosy susceptibility (odds ratio (OR) ¼ 1.40; P ¼ 0.01).
    [Show full text]
  • PLINK: a Toolset for Whole Genome Association and Population-Based Linkage Analyses
    1 PLINK: a toolset for whole genome association and population-based linkage analyses Shaun Purcell1,2, Benjamin Neale1,2,3, Kathe Todd-Brown1, Lori Thomas1, Manuel A R Ferreira1, David Bender1,2, Julian Maller1,2, Paul I W de Bakker1,2, Mark J Daly1,2, Pak C Sham4 1 Center for Human Genetic Research, MGH, Boston, USA. 2 Broad Institute of Harvard and MIT, Cambridge, USA. 3 Institute of Psychiatry, University of London, London, UK. 4 Genome Research Center, University of Hong Kong, Pokfulam, Hong Kong. Correspondence: Shaun Purcell, Rm 6.254, CPZ-N, 185 Cambridge Street, Boston, MA, 02114, USA; Tel: 617-726-7642; Fax: 617-726-0830; [email protected] Keywords : Whole genome association studies, single nucleotide polymorphisms, identity-by-state, identity-by-descent, linkage analysis, computer software Abstract Whole-genome association studies (WGAS) bring new computational as well as analytic challenges to researchers. Many existing genetic analysis tools are not designed to handle such large datasets in a convenient manner and do not necessarily exploit the new opportunities that whole-genome data bring. To address these issues, we developed PLINK, an open source C/C++ WGAS toolset. Large datasets, comprising hundreds of thousands of markers geno- typed for thousands of individuals, can be rapidly manipulated and analyzed in their entirety. As well as providing tools to make the basic analytic steps computationally efficient, PLINK also supports some novel approaches to whole-genome data, that take advantage of whole-genome coverage. We in- troduce PLINK and describe the five main domains of function: data man- agement, summary statistics, population stratification, association analysis and identity-by-descent estimation.
    [Show full text]
  • Next Generation Exome Sequencing of Paediatric Inflammatory Bowel
    Inflammatory bowel disease ORIGINAL ARTICLE Next generation exome sequencing of paediatric Gut: first published as 10.1136/gutjnl-2011-301833 on 28 April 2012. Downloaded from inflammatory bowel disease patients identifies rare and novel variants in candidate genes Katja Christodoulou,1 Anthony E Wiskin,2 Jane Gibson,1 William Tapper,1 Claire Willis,2 Nadeem A Afzal,3 Rosanna Upstill-Goddard,1 John W Holloway,4 Michael A Simpson,5 R Mark Beattie,3 Andrew Collins,1 Sarah Ennis1 < Additional materials are ABSTRACT published online only. To view Background Multiple genes have been implicated by Significance of this study these files please visit the association studies in altering inflammatory bowel journal online (http://dx.doi.org/ 10.1136/gutjnl-2011-301833). disease (IBD) predisposition. Paediatric patients often What is already known on this subject? manifest more extensive disease and a particularly < For numbered affiliations see Genome-wide association studies have impli- end of article. severe disease course. It is likely that genetic cated numerous candidate genes for inflamma- predisposition plays a more substantial role in this group. tory bowel disease (IBD), but evidence of Correspondence to Objective To identify the spectrum of rare and novel causality for specific variants is largely absent. Dr Sarah Ennis, Genetic variation in known IBD susceptibility genes using exome Furthermore, by design, genome-wide associa- Epidemiology and Genomic sequencing analysis in eight individual cases of childhood Informatics Group, Human tion studies are limited to the study of Genetics, Faculty of Medicine, onset severe disease. common variants and overlook the functionally University of Southampton, Design DNA samples from the eight patients underwent detrimental variation imposed by rare/novel Duthie Building (Mailpoint 808), targeted exome capture and sequencing.
    [Show full text]
  • Basics in Genetics Analysis
    Genetics and Diseases Basics in Genetics Analysis Heping Zhang Environment 9/24/2007 Dr. Doug Brutlag Lecture Syllabus “central paradigm” //www.s-star.org/ 2 Diseases Progression Known and Probable Risk Factors z Being a woman How does the Breast Cancer grows and spread? z Getting older z Having a personal history of BC or ovarian cancer z Having a family history of breast cancer z Having a previous biopsy showing carcinoma in situ z Having your first period before age 12 z Starting menopause after age 55 A malignant Malignant Cancer cells z Never having children tumor within tumors spread z Having your first child after age 30 the breast suppress z Having a mutation in the BRCA1 or BRCA2 genes normal ones z Drinking more than 1 alcoholic drink per day z Being overweight after menopause or gaining weight as an adult. 9/24/2007 3 9/24/2007 4 Genetic Epidemiology Terminology • How is a disease transmitted in families? ( Marker: a known DNA sequence that can be identified by a Inheritance patterns). simple assay e.g., D1S80, D4S43, D16S126 • What is the recurrence Allele: a viable DNA coding that occupies a given locus risk for relatives? (position) on a chromosome e.g., A, a; • Mendelian disorders Genotype: the observed alleles at a genetic locus for an • Autosomal or X-linked individual • Dominant or recessive e.g., AA, Aa, aa; 0 Homozygous: AA, aa 0 Heterozygous: Aa Phenotype: the expression of a particular genotype 0 Continuous: blood pressure 0 Dichotomous: Cancer, Hypertension 9/24/2007 Duke University Center of Human Genetics 5 9/24/2007 6 1 Mendel’s Laws DNA Polymorphism and Human Variation First Law Segregation of Characteristics: the sex cell of a plant or animal may contain one factor (allele) for different traits but not both factors needed to express the traits.
    [Show full text]
  • Genetic Association Tests for Binary Traits with An
    GENETIC ASSOCIATION TESTS FOR BINARY TRAITS WITH AN APPLICATION by SULGI KIM Submitted in partial fulfillment of the requirements For the degree of Doctor of Philosophy Dissertation Advisor: Dr. Robert C. Elston Department of Epidemiology and Biostatistics CASE WESTER RESERVE UNIVERSITY August, 2009 CASE WESTERN RESERVE UNIVERSITY SCHOOL OF GRADUATE STUDIES We hereby approved the dissertation of Sulgi Kim candidate for the Ph. D. degree*. (Signed) Robert C. Elston, Ph.D Department of Epidemiology and Biostatistics Chair of the committee Xiaofeng Zhu, Ph.D Department of Epidemiology and Biostatistics Courtney Gray-McGuire, Ph.D Department of Epidemiology and Biostatistics Jill S. Barnholtz-Sloan, Ph.D Case Comprehensive Cancer Center June 8, 2009 *We also certify that written approval has been obtained for any proprietary material therein. ii Table of Contents List of Tables .................................................................................................................... iv List of Figures .....................................................................................................................v Acknowledgements .......................................................................................................... vi Abstract ...............................................................................................................................1 Chapter 1. Introduction.....................................................................................................3 Chapter 2. Association Tests
    [Show full text]
  • Design and Analysis of Genetic Association Studies
    ection S ON Design and Analysis of Statistical Genetic Association G enetics Studies Hemant K Tiwari, Ph.D. Professor & Head Section on Statistical Genetics Department of Biostatistics School of Public Health Association Analysis • Linkage Analysis used to be the first step in gene mapping process • Closely located SNPs to disease locus may co- segregate due to linkage disequilibrium i.e. allelic association due to linkage. • The allelic association forms the theoretical basis for association mapping Linkage vs. Association • Linkage analysis is based on pedigree data (within family) • Association analysis is based on population data (across families) • Linkage analyses rely on recombination events • Association analyses rely on linkage disequilibrium • The statistic in linkage analysis is the count of the number of recombinants and non-recombinants • The statistical method for association analysis is “statistical correlation” between Allele at a locus with the trait Linkage Disequilibrium • Over time, meiotic events and ensuing recombination between loci should return alleles to equilibrium. • But, marker alleles initially close (genetically linked) to the disease allele will generally remain nearby for longer periods of time due to reduced recombination. • This is disequilibrium due to linkage, or “linkage disequilibrium” (LD). Linkage Disequilibrium (LD) • Chromosomes are mosaics Ancestor • Tightly linked markers Present-day – Alleles associated – Reflect ancestral haplotypes • Shaped by – Recombination history – Mutation, Drift Tishkoff
    [Show full text]
  • Abstracts for the ??Evolutionary Medicine Conference
    Ashdin Publishing Journal of Evolutionary Medicine ASHDIN Vol. 3 (2015), Article ID 235924, 45 pages publishing doi:10.4303/jem/235924 Abstracts CONFERENCE PROCEEDINGS Abstracts for the “Evolutionary Medicine Conference: Interdisciplinary Perspectives on Human Health and Disease” at the University of Zurich, Switzerland (July 30–August 1, 2015) Kaspar Staub,1 Nicole Bender,2 Paul Ewald,3 and Frank Ruhli¨ 1 1Institute of Evolutionary Medicine, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland 2Institute of Social and Preventive Medicine, University of Bern, Finkenhubelweg 11, CH-3012 Bern, Switzerland 3Department of Biology, University of Louisville, Louisville, KY 40292, USA Address correspondence to Frank Ruhli,¨ [email protected] Received 17 Aril 2015; Revised 11 May 2015; Accepted 14 May 2015 Copyright © 2015 Kaspar Staub et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Summary In summer 2015, the “Evolutionary Medicine Conference diseases. The discipline is now at a turning point at which a 2015: Interdisciplinary Perspectives on Human Health and Disease” rigorous application of evolutionary insights to the medical takes place at the Institute of Evolutionary Medicine, University of sciences will require not only assessing the validity of the Zurich, Switzerland. This international conference is the first of its kind in Europe and brings together eight distinguished keynote speak- full spectrum of possible explanations for each disease ers from all over the world as well as experts from different disci- but the interplay of different contributors to illness within plines (including medicine, anthropology, molecular/evolutionary biol- and between the three broad categories of causal factors: ogy, paleopathology, archeology, history, psychology, epidemiology, genetic, infectious, and environmental.
    [Show full text]
  • BIOL 5112/3112: Fundamentals of Genomic Evolutionary Medicine
    BIOL 5112/3112: Fundamentals of Genomic Evolutionary Medicine Dr. Sudhir Kumar 602A SERC s.kumar@ temple.edu LECTURE BioLife Science 332 Wednesday: 5:30-8:00 pm OFFICE HOURS By appointment Offered in the Spring semester BIOL 5112 SECTION 001 [26318] (For graduate students) BIOL 3112 SECTION 001 [27340] (For undergraduate students) (Graduates and undergraduate attend the lectures together at the same time in the same room. However, undergraduate students will work in small groups in the semester-long student case study projects. Graduate students will work individually on case-study projects.) Prerequisite: Biology 2112 with a grade of C or better. Course Description: Modern evolutionary theory offers a conceptual framework for understanding human health and disease. In this course we will examine human disease in evolutionary contexts with a focus on modern techniques and genome-scale datasets. We ask: What can evolution teach us about human populations? How can we understand disease from molecular evolutionary perspectives? What are the relative roles of negative and positive selection in disease? How do we apply evolutionary principles in to diagnose diseases and develop better treatments? Students will become familiar with current research through guided case studies. This course focuses on discovery-based learning. Course Learning Objectives 1. Explain key concepts of evolutionary biology and medicine from a genomic perspective 2. Integrate key evolutionary concepts and principles to explain various aspects of human health and disease 3. Develop familiarity with current research relevant to evolutionary and genomic medicine 4. Evaluate how genomics and phylomedicine fit into the broader context of modern healthcare 5.
    [Show full text]
  • An Evolutionary Telescope to Explore and Diagnose the Universe of Disease Mutations
    Review Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations Sudhir Kumar1,2, Joel T. Dudley3,4, Alan Filipski1,2 and Li Liu2 1 School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, USA 2 Center for Evolutionary Medicine and Informatics, The Biodesign Institute, Arizona State University, Tempe, AZ 85287-5301, USA 3 Division of Systems Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA 4 Biomedical Informatics Training Program, Stanford University School of Medicine, Stanford, CA 94305, USA Modern technologies have made the sequencing of per- robust picture of the amount and types of variations found sonal genomes routine. They have revealed thousands within and between human individuals and populations. of nonsynonymous (amino acid altering) single nucleo- Any one personal genome contains more than a million tide variants (nSNVs) of protein-coding DNA per ge- variants, the majority of which are single nucleotide var- nome. What do these variants foretell about an iants (SNVs) (Figure 1b). With the complete sequencing of individual’s predisposition to diseases? The experimen- each new genome, the number of novel variants discovered tal technologies required to carry out such evaluations at is decreasing, but the total number of known variants is a genomic scale are not yet available. Fortunately, the growing quickly (Figure 2a). Our knowledge of the number process of natural selection has lent us an almost infinite of disease genes and the total number of known disease- set of tests in nature. During long-term evolution, new associated SNVs has grown with these advances [12].
    [Show full text]
  • Genome-Wide Association Studies: Understanding the Genetics of Common Disease the Academy of Medical Sciences | FORUM
    The Academy of Medical Sciences | FORUM Genome-wide association studies: understanding the genetics of common disease Symposium report July 2009 The Academy of Medical Sciences The Academy of Medical Sciences promotes advances in medical science and campaigns to ensure these are converted into healthcare benefits for society. Our Fellows are the UK’s leading medical scientists from hospitals and general practice, academia, industry and the public service. The Academy seeks to play a pivotal role in determining the future of medical science in the UK, and the benefits that society will enjoy in years to come. We champion the UK’s strengths in medical science, promote careers and capacity building, encourage the implementation of new ideas and solutions – often through novel partnerships – and help to remove barriers to progress. The Academy’s FORUM with industry The Academy’s FORUM is an active network of scientists from industry and academia, with representation spanning the pharmaceutical, biotechnology and other health product sectors, as well as trade associations, Research Councils and other major charitable research funders. Through promoting interaction between these groups, the FORUM aims to take forward national discussions on scientific opportunities, technology trends and the associated strategic choices for healthcare and other life-science sectors. The FORUM builds on what is already distinctive about the Academy: its impartiality and independence, its focus on research excellence across the spectrum of clinical and basic sciences and its commitment to interdisciplinary working. Acknowledgements This report provides a summary of the discussion at the FORUM symposium on ‘Genome-wide association studies’ held in October 2008.
    [Show full text]
  • Study of Genetic Association
    Statistical Genomics and Bioinformatics Workshop 8/16/2013 Statistical Genomics and Bioinformatics Workshop: Genetic Association and RNA-Seq Studies Population Genetics and Genome‐wide Genetic Association Studies (GWAS) Brooke L. Fridley, PhD University of Kansas Medical Center 1 Study of Genetic Association Cases Controls Genetic association studies look at the frequency of genetic changes in a group of cases and controls to try to determine whether specific changes are associated with disease. 2 1 Statistical Genomics and Bioinformatics Workshop 8/16/2013 Genetic Analysis Strategies Linkage effect GWAS Association size Rare Variant Analysis allele frequency Ardlie, Kruglyak & Seielstad (2002) Nature Genetics Reviews Zondervan & Cardon (2004) Nature Genetics Reviews 3 Genetics of Complex Traits • Multiple genes / variants – Common and rare variants – Interactions, Haplotypes, Pathways • Environment – Gene‐Environment interaction 4 2 Statistical Genomics and Bioinformatics Workshop 8/16/2013 In reality, much more complex! 5 NIHGRI GWAS Catalog (8/11/2013) http://www.genome.gov/gwastudies/ 6 3 Statistical Genomics and Bioinformatics Workshop 8/16/2013 Population Genetics 7 Recombination A1 B1 D1 Before meioses A2 B2 D2 A1 B1 D2 Crossovers occur during meioses A2 B2 D1 D2 A1 B1 After recombination A2 B2 D1 8 4 Statistical Genomics and Bioinformatics Workshop 8/16/2013 Linkage Disequilibrium (LD) • Particular alleles at neighboring loci tend to be co-inherited. • For tightly linked loci, this co-inheritance might lead to associations between
    [Show full text]